Paul Robinson - Articles and news items

MSD Logo

New data at ACR meeting show efficacy of Simponi® (golimumab) in treating patients with active non-radiographic axial spondyloarthritis

Industry news / 19 November 2014 / MSD

Application for approval of new indication for golimumab has been filed with the European Medicines Agency…

Merck logo

Ulcerative colitis not well-controlled in patients receiving conventional treatments

Industry news / 21 February 2014 / Merck

MSD has announced full study findings from a pan-European observational study that showed the majority of moderate-to-severe ulcerative colitis patients who were treated with conventional therapies failed to achieve well-controlled disease status…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...